López De Padilla, Consuelo M <br/><br/>
Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab.  [electronic resource] 

 -  Clinical and experimental rheumatology   
 - 655-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0392-856X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents--therapeutic use<br/>Biomarkers--blood<br/>Cells, Cultured<br/>Chemokines--blood<br/>Female<br/>Humans<br/>Interferon-alpha--pharmacology<br/>Lymphocyte Activation--drug effects<br/>Male<br/>Middle Aged<br/>Myositis--blood<br/>Predictive Value of Tests<br/>Remission Induction<br/>Rituximab--therapeutic use<br/>Severity of Illness Index<br/>T-Lymphocytes, Regulatory--drug effects<br/>Time Factors<br/>Treatment Outcome<br/>United States<br/>Young Adult